CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC=Breast

PDF] Long-term outcomes of invasive ipsilateral breast tumor

The impact of erythropoiesis-stimulating agents administration

Comparison of Breast Cancer Recurrence and Outcome Patterns

Impact of HER2-low status for patients with early-stage breast

Mixed invasive ductal lobular carcinoma is clinically and

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

Phase II trial of preoperative paclitaxel, gemcitabine, and

CONSORT Diagram: NSABP B-36. a QOL sub-study. b MH sub-study. c

Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel

Long‐term cardiac safety and outcomes of dose‐dense doxorubicin

View of Abemaciclib (Verzenio) Canadian Journal of Health

Alterations in immune cell phenotype and cytotoxic capacity in

Neoadjuvant chemotherapy for stage II–III breast cancer: a single

Frontiers Triple-negative and Her2-positive breast cancer in

CONSORT diagram. aPatients who had surgery; bPatients with